MedPath
TGA Approval

RAPIVAB peramivir 200 mg / 20 mL concentrate for intravenous infusion glass vial (285559)

285559

RAPIVAB peramivir 200 mg / 20 mL concentrate for intravenous infusion glass vial

Biocelect Pty Ltd

March 21, 2018

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/af4acc9033b30e0079b7074191040cc4.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/11dcb4ae488d9659632d25bc99ac4968.pdf

Active Ingredients

peramivir

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

RAPIVAB peramivir 200 mg / 20 mL concentrate for intravenous infusion glass vial (285559) - TGA 批准文号 | MedPath